Personal information

Activities

Collapse all

Employment (6)

Universidad Pablo de Olavide: Sevilla, Andalucía, ES

2022-01-17 to present | Professor (Molecular Biology and Biochemical Engineering Dept. Microbiology Area)
Employment
Source: Self-asserted source
YOUNES SMANI

Institute of Health Carlos III: Madrid, ES

2021-06-08 to 2022-01-16 | Miguel Servet Researcher II
Employment
Source: Self-asserted source
YOUNES SMANI

Institute of Health Carlos III: Seville, -- select state --, ES

2016-01-08 to 2021-06-07 | Miguel Servet Researcher I (Infectious Diseases)
Employment
Source: Self-asserted source
YOUNES SMANI

Institute of Biomedicine of Seville: Seville, -- select state --, ES

2007-01-01 to 2016-01-07 | Postdoctoral Researcher (Infectious Diseases)
Employment
Source: Self-asserted source
YOUNES SMANI

University Hospital Virgen del Rocío: Seville, -- select state --, ES

2007-10-24 to 2012-12-31 | Postdoctoral Researcher (Infectious Diseases)
Employment
Source: Self-asserted source
YOUNES SMANI

Faculty of Pharmacy and Faculty of Sciences and Techniques, University of Henri Poincaré: Nancy, FR

2006-10-01 to 2007-07-31 | Teaching associate (Hematology and Physiology)
Employment
Source: Self-asserted source
YOUNES SMANI

Education and qualifications (5)

Faculty of Pharmacy, University of Henri Poincaré: Nancy, FR

2003-09-01 to 2006-11-15 | PhD (Hematology and Physiology)
Education
Source: Self-asserted source
YOUNES SMANI

Faculty of Pharmacy, University of Henri Poincaré: Nancy, FR

2002-09-01 to 2003-07-31 | Master of Clinical Pharmacology (Hematology and Physiology)
Education
Source: Self-asserted source
YOUNES SMANI

Faculty of Sciences, University of Henri Poincaré: Nancy, FR

2001-09-01 to 2002-06-30 | Degree in Cellular Biology and Animal Physiology
Education
Source: Self-asserted source
YOUNES SMANI

Faculty of Sciences, University of My Ismail: Méknès, MA

2000-09-01 to 2001-06-30 | Degree in Biology
Education
Source: Self-asserted source
YOUNES SMANI

High School: Méknès, MA

1996-09-01 to 1997-06-30 | High School diploma
Education
Source: Self-asserted source
YOUNES SMANI

Funding (21)

Estudio clínico y microbiológico del impacto del tratamiento con piperacilina/tazobactam (P/T) en pacientes con infecciones intraabdominales por Escherichia coli portadores de beta-lactamasas.

2020-01-01 to 2022-12-31 | Grant
Instituto de Salud Carlos III (Madrid, ES)
URL: https://app.dimensions.ai/details/grant/grant.9667932
GRANT_NUMBER: PI19/01009
Source: Self-asserted source
YOUNES SMANI via DimensionsWizard

Eficacia terapéutica de la lisofosfatidilcolina con dosis múltiples y combinada con antibióticos en modelos experimentales de infecciones causados por bacilos gramnegativos multirresistentes

2017-01 to 2019-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PI16/01306
Source: Self-asserted source
YOUNES SMANI

Eficacia terapéutica de la oxiclozanida como terapia combinada con colistina in vitro y en modelos experimentales murinos de infecciones graves

2017-01 to 2019-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PI16/01378
Source: Self-asserted source
YOUNES SMANI
grade
Preferred source (of 2)‎

Miguel Servert Program

2016-01 to 2020-12 | Salary award
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

MS15-00132G
Source: Self-asserted source
YOUNES SMANI

Eficacia terapéutica de MV5 y sus derivados como terapia combinada con colistina en un modelo experimental murino de infección grave por bacilos Gramnegativos

2016-01 to 2018-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PI15-01358
Source: Self-asserted source
YOUNES SMANI

Overexpression of outer membrane protein A (OmpA) as a risk factor for mortality in bacteremia by E. coli and K. pneumoniae

2016-01 to 2018-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

CP15-00132
Source: Self-asserted source
YOUNES SMANI

Respuesta inmunitaria celular, innata y adaptativa, en las infecciones por A. baumannii y P. aeruginosa. Eficacia de células de memoria en modelos experimentales de sepsis por A. baumannii y P. aeruginosa

2016-01 to 2018-12 | Grant
Fundación Progreso y Salud, Junta de Andalucía (Seville, ES)
GRANT_NUMBER:

PI-0099-14
Source: Self-asserted source
YOUNES SMANI

Efficacy studies of pro-drug CSA-97MS against a clinical colistin-resistant Acinetobacter baumannii

2015-01 to 2015-12 | Grant
N8 Medical, Inc (Utah, US)
GRANT_NUMBER:

FISEVI/15/0010
Source: Self-asserted source
YOUNES SMANI

Eficacia terapéutica de la lisofosfatidilcolina como terapia combinada con antibióticos en modelos experimentales murinos de infecciones graves

2014-01 to 2016-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PI13-01744
Source: Self-asserted source
YOUNES SMANI

Translating hypoxia research to a clinical setting: o2 deficiency tolerance, brain dysfunction, infection, and cancer

2014-01 to 2016-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PIE13-00004
Source: Self-asserted source
YOUNES SMANI

Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplants recipients dynamics of colonization, serotypes distribution, and antimicrobial resistance

2014-01 to 2015-12 | Grant
PFIZER, S.A (USA, US)
Source: Self-asserted source
YOUNES SMANI

Spanish Network Research in Infectious Diseases

2013-01 to 2016-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

RD12/0015/0001
Source: Self-asserted source
YOUNES SMANI

Estudio de la eficacia terapéutica de los inhibidores de la proteína de membrana externa A (OmpA) en modelos murinos de infección por A. baumannii multiresistente y panresistente

2013-01 to 2015-12 | Grant
Consejería de Salud, Junta de Andalucía. (Seville, ES)
GRANT_NUMBER:

PI-0069
Source: Self-asserted source
YOUNES SMANI

Estudio de los genes responsables de la patogenicidad de A. baumannii en cepas clínicas productoras de infección y colonización

2013-01 to 2015-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

PI12-02553
Source: Self-asserted source
YOUNES SMANI

Efficacy of ceftaroline vs. vancomycin in the treatment of experimental foreign body infection by methicillin-resistant Staphylococcus epidermidis.

2013-01 to 2013-12 | Grant
AstraZeneca (Madrid, ES)
Source: Self-asserted source
YOUNES SMANI

Caracterización de la respuesta inflamatoria inducida por A.baumannii y eficacia terapéutica de la lisofosfatidilcolina en modelos murinos de infección por este patógeno nosocomial

2011-04 to 2015-04 | Grant
Consejería de Economía, Innovación, Ciencia y de Empleo, Junta de Andalucía. (Seville, ES)
GRANT_NUMBER:

CTS/6317
Source: Self-asserted source
YOUNES SMANI

Estudio de la patogenicidad y virulencia de cepas clínicas, productoras de colonización o de infección, de Acinetobacter baumannii

2010-01 to 2012-12 | Grant
Institute of Health Carlos III (Mardrid, ES)
GRANT_NUMBER:

PS09/01427
Source: Self-asserted source
YOUNES SMANI

Estudio de nuevas vías moleculares implicadas en la apoptosis inducida por cepas de Acinetobacter baumannii. Papel de la rifampicina como inhibidor de la apoptosis

2009-01 to 2011-12 | Grant
Consejería de Salud, Junta de Andalucía. (Seville, ES)
GRANT_NUMBER:

PI-0383/2007
Source: Self-asserted source
YOUNES SMANI

Efficacy of Daptomycin vs. Vancomycin in the treatment of experimental foreign body infection by methicillin resistant Staphylococcus epidermidis.

2009-01 to 2010-12 | Grant
Novartis Pharma (Madrid, ES)
Source: Self-asserted source
YOUNES SMANI

Spanish Network Research in Infectious Diseases

2007-01 to 2010-12 | Grant
Institute of Health Carlos III (Madrid, ES)
GRANT_NUMBER:

RD06/0008/0000
Source: Self-asserted source
YOUNES SMANI

Evaluation et compréhension des effets indésirables des transporteurs à base d’hémoglobine

2001-01 to 2004-12 | Grant
Ministère de l’Enseignement Supérieur de France (Paris, FR)
GRANT_NUMBER:

EA3452
Source: Self-asserted source
YOUNES SMANI
grade
Preferred source (of 2)‎

Peer review (84 reviews for 33 publications/grants)

Review activity for Annals of clinical microbiology and antimicrobials. (4)
Review activity for Antibiotics. (2)
Review activity for Antimicrobial agents and chemotherapy. (4)
Review activity for Applied sciences. (1)
Review activity for Biomolecules. (1)
Review activity for Clinical microbiology and infection. (1)
Review activity for Diagnostics. (2)
Review activity for eLife (1)
Review activity for Emerging microbes & infections. (1)
Review activity for Expert opinion on pharmacotherapy (2)
Review activity for Future microbiology. (3)
Review activity for Infection and immunity. (1)
Review activity for Infectious diseases and therapy. (1)
Review activity for Infectious disorders. (1)
Review activity for International journal of environmental research and public health (3)
Review activity for International journal of molecular sciences. (9)
Review activity for Journal of antimicrobial chemotherapy. (10)
Review activity for Journal of biomedical science (1)
Review activity for Journal of clinical medicine. (2)
Review activity for Journal of peptide science (1)
Review activity for Materials. (1)
Review activity for Microbiology spectrum. (2)
Review activity for Microorganisms. (4)
Review activity for Molecules. (9)
Review activity for MSystems. (2)
Review activity for Nanomaterials. (5)
Review activity for Nature communications (1)
Review activity for Pathogens. (2)
Review activity for Pharmaceutics. (1)
Review activity for The journal of antimicrobial chemotherapy. (1)
Review activity for Therapeutic advances in infectious disease. (3)
Review activity for Toxins. (1)
Review activity for Water. (1)
How many people are using ORCID?